Reaction Details
Report a problem with these data
Report a problem with these dataTarget
11-beta-hydroxysteroid dehydrogenase type 2
Ligand
BDBM50277203
Substrate
n/a
Meas. Tech.
ChEBML_1717701
IC50
100±n/a nM
Citation
Leiva, R; Griñan-Ferré, C; Seira, C; Valverde, E; McBride, A; Binnie, M; Pérez, B; Luque, FJ; Pallàs, M; Bidon-Chanal, A; Webster, SP; Vázquez, S Design, synthesis and in vivo study of novel pyrrolidine-based 11?-HSD1 inhibitors for age-related cognitive dysfunction. Eur J Med Chem 139:412-428 (2017) [PubMed] Article More Info.:
Target
Name:
11-beta-hydroxysteroid dehydrogenase type 2
Synonyms:
11-DH2 | 11-beta-HSD2 | 11-beta-Hydroxysteroid Dehydrogenase 2 (11-beta-HSD2) | 11-beta-hydroxysteroid dehydrogenase | 11-beta-hydroxysteroid dehydrogenase 2 | 11-beta-hydroxysteroid dehydrogenase type 2 | 11-beta-hydroxysteroid dehydrogenase type 2 (11-beta-HSD2) | Corticosteroid 11-beta-dehydrogenase isozyme 2 | DHI2_HUMAN | HSD11B2 | HSD11K | NAD-dependent 11-beta-hydroxysteroid dehydrogenase | SDR9C3
Type:
Enzyme
Mol. Mass.:
44141.72
Organism:
Homo sapiens (Human)
Description:
Purified recombinant human 11beta-HSD2.
Residue:
405
Sequence:
MERWPWPSGGAWLLVAARALLQLLRSDLRLGRPLLAALALLAALDWLCQRLLPPPAALAVLAAAGWIALSRLARPQRLPVATRAVLITGCDSGFGKETAKKLDSMGFTVLATVLELNSPGAIELRTCCSPRLRLLQMDLTKPGDISRVLEFTKAHTTSTGLWGLVNNAGHNEVVADAELSPVATFRSCMEVNFFGALELTKGLLPLLRSSRGRIVTVGSPAGDMPYPCLGAYGTSKAAVALLMDTFSCELLPWGVKVSIIQPGCFKTESVRNVGQWEKRKQLLLANLPQELLQAYGKDYIEHLHGQFLHSLRLAMSDLTPVVDAITDALLAARPRRRYYPGQGLGLMYFIHYYLPEGLRRRFLQAFFISHCLPRALQPGQPGTTPPQDAAQDPNLSPGPSPAVAR
Inhibitor
Name:
BDBM50277203
Synonyms:
CHEMBL4170932
Type:
Small organic molecule
Emp. Form.:
C17H27NO
Mol. Mass.:
261.4024
SMILES:
O=C(C1CCCCC1)N1CC2C(C1)C1CCC2CC1 |TLB:9:10:15.14:17.18,12:11:15.14:17.18,(11.97,-36.21,;11.94,-34.68,;13.26,-33.89,;14.6,-34.64,;15.91,-33.86,;15.9,-32.32,;14.55,-31.57,;13.23,-32.36,;10.6,-33.93,;9.04,-33.74,;8.64,-32.35,;9.4,-30.93,;9.64,-32.74,;7.7,-30.37,;6.13,-31.11,;5.44,-32.57,;7.11,-31.74,;6.73,-30.35,;7.25,-28.69,)|
Structure:
